General Discussions

FDA Approves Eribulin for Metastatic Liposarcoma

Richard Pazdur, MD The FDA has approved eribulin mesylate (Halaven) to treat patients with advanced or unresectable liposarcoma following prior treatment with an anthracycline-based chemotherapy....

Symptom Management in Oncology Nursing-

Susan C. McMillan, PhD, ARNP, FAAN Despite decades of research, experts agree that, for many patients with advanced cancer, clinicians may still fail to accurately assess—or sufficien...

What Would You Do: Would you use an implanted port that lacked a blood return to administer non-vesicant chemotherapy?

The “What Would You Do?” column answers clinical questions on topics for which evidence is lacking or controversial. Oncology nursing and vascular access leaders provide their expert o...


 Have you ever used superglue and accidentally got a little on your finger and before you know it there is an instant bond between two fingers?   How is it that it can bond so fast?...

Nivolumab Gets FDA Approval for Head and Neck Cancer

There’s a new indication for the checkpoint inhibitor nivolumab (Opdivo), with the FDA’s approval November 10 of the agent for patients with metastatic or recurrent squamous cell carci...

Don't Forget the Partner of a Patient With Cancer

Linda M. Goodfellow, PhD, RN   Associate Professor, Duquesne University School of Nursing, Pittsburgh, PA. Family systems theory emphasizes the interrelatedness of family membe...

E-Cigarette Use and Bladder Cancer Risk: There May Be a Link

Findings of a pilot study offer more support for the link between smoking and bladder cancer—in this case, a possible elevated risk for the disease due to e-cigarette use.   In an inter...

Calling a Chemo Nurse: Pager Program Promotes Safe Chemotherapy Practice

Monica Fradkin, RN, BSN, MPH, OCN, Kelli-Ann Choun, RN, BSN, OCN Kirsten Pedersen, RN, BSN, OCN Sarah Tonucci, RN, MSN, OCN   Monica Fradkin, RN, BSN, MPH, ...

External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.